Novel Approach to Antiseizure Drug Development With Use of Long Episodes: Jacqueline A. French, MD
December 17th 2024The professor of neurology at NYU Grossman School of Medicine discussed a pioneering study using long seizure episodes to optimize treatment devices and identify effective antiseizure drugs in epilepsy care. [WATCH TIME: 2 minutes]
Overviewing Positive Phase 2 Data on Potassium Channel Inhibitor XEN1101: Jacqueline French, MD
October 28th 2024The professor of neurology at NYU Grossman School of Medicine discussed the results of a phase 2b study on XEN1101, an investigational drug in development for focal epilepsy. [WATCH TIME: 4 minutes]
Mechanism and Promise Behind XEN1101 in Focal Epilepsy: Jacqueline French, MD
October 24th 2024The professor of neurology at NYU Grossman School of Medicine provided clinical insight on the uniqueness of investigational XEN1101 and the idea behind potassium channel inhibitors to treat epilepsy. [WATCH TIME: 3 minutes]
Importance of Nonmotor Features When Diagnosing Epilepsy in Adolescents
May 9th 2024Jacqueline A. French, MD, professor of neurology at NYU Grossman School of Medicine, provided comments on a recently published study explaining the issues with diagnosing epilepsy in emergency department settings.
Addressing Potential Causes of Burnout Through Productive Solutions: Neil Busis, MD
May 3rd 2024The associate chair for technology and innovation at the NYU Grossman School of Medicine provided commentary on a study from AAN 2024 that examined the driving factors behind burnout in neurology departments. [WATCH TIME: 4 minutes]
Understanding the Clinical Utility of Low-Contrast Letter Acuity and RAN Tasks in Alzheimer Disease
April 23rd 2024Lauren Seidman, a second-year medical student at NYU Langone’s Grossman School of Medicine, provided perspective on a poster at AAN 2024 highlighting the use of binocular visual function testing in Alzheimer disease.
Raising Awareness for the Lasting Effects of Traumatic Brain Injury: Shae Datta, MD
March 12th 2024The neurologist and migraine expert at NYU Langone Health provided perspective on TBI Awareness Month and the importance of accurate detection and swift care for trauamatic brain injury. [WATCH TIME: 4 minutes]
Treatment Options and Outcomes of Cervical Artery Dissection in Adults: Eytan Raz, MD, PhD
February 27th 2024The neurointerventional radiologist at NYU Langone provided clarity on the individualized treatment options for cervical artery dissection following a scientific statement paper from the American Heart Association. [WATCH TIME: 7 minutes]
Epilepsy Awareness and First Aid for Seizures in 2024: Claude Steriade, MD, CM
February 13th 2024The epileptologist at NYU Langone Health and associate professor of neurology at NYU Grossman School of Medicine talked about the ongoing need to improve public awareness and education on seizure first aid. [WATCH TIME: 3 minutes]
A Conversation on Women's Leadership and Career in Medicine: Jennifer Frontera, MD
February 3rd 2024The professor of neurology at NYU Grossman School of Medicine talked about the importance of aligning leadership roles with personal passions for women in the field of neurology pursuing their careers in medicine. [WATCH TIME: 5 minutes]
2024 Clinical Preview for Epilepsy and Seizure Disorders: Claude Steriade, MD, CM
January 22nd 2024The epileptologist at NYU Langone Health and associate professor of neurology at the NYU Grossman School of Medicine shared her thoughts on potential therapies and expanding management care options for patients with epilepsy in the near future. [WATCH TIME: 5 minutes]
Assessing Video Evidence to Understand Sudden Unexplained Death in Children: Orrin Devinsky, MD
January 19th 2024The director of NYU Langone’s Comprehensive Epilepsy Center discussed a recently published study that used videos to identify potential causes of sudden deaths in toddlers. [WATCH TIME: 4 minutes]
Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches
December 8th 2023While specialists still debate the diagnostics of impaired cognition, the identification of patients at the earliest stages is beginning to be met through new biomarkers and available assays.
Potassium Channel Opener XEN1101 Offers Simplicity and Strong Efficacy in Seizure Control
October 10th 2023Jacqueline French, MD, professor of neurology at NYU Grossman School of Medicine and chief medical officer of the Epilepsy Foundation, talked about findings from a newly published study assessing XEN1101 in patients with drug-resistant epilepsy.
Championing Women's Leadership in Neurology: Jennifer Frontera, MD
October 1st 2023The professor of neurology at NYU Langone Grossman School of Medicine discussed the Women in Neurology session she gave at IFN 2023, where women shared their experiences from their medical careers. [WATCH TIME: 3 minutes]
Targeting Cognitive Impairment of Long COVID With Brain Stimulation
September 21st 2023Leigh Charvet, PhD, professor of neurology at the NYU Grossman School of Medicine, talked about a trial that aims to address cognitive impairment in patients with long COVID through a unique, remote, and home-based treatment approach.